Related Experiment Video

Updated: Apr 22, 2026

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

18.3K

Human monoclonal antibodies produced by immortalization with Epstein-Barr virus

M Steinitz1, E Klein1

  • 1Department of Hematology, Hadassah University Hospital, Jerusalem, Israel; Department of Tumour Biology, Karolinska Institutet, Stockholm, Sweden.

Immunology Today
|October 8, 2014
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.0K
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
06:38

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

42.0K

Related Experiment Videos

Last Updated: Apr 22, 2026

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

18.3K
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.0K
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
06:38

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

42.0K

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

13.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.0K

Articles linked to this work by shared authors, journal, and citation graph.

Generation of cytotoxicity with various MHC class I restrictions against autologous LCL by stimulating the lymphocytes with autologous and/or allogeneic LCLs sharing HLA alleles with the responder.

Cellular immunology·1992

HLA-B5-restricted auto-tumor-specific cytotoxic T cells generated in mixed lymphocyte-tumor-cell culture.

International journal of cancer·1992

A trypsin-like serine protease activity on activated human B cells and various B cell lines.

European journal of immunology·1992

Characteristic ionic composition of endolymph is maintained in cultured inner ear.

Acta oto-laryngologica·1992

MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).

International journal of cancer·1992

Assembly of MHC class I molecules in ex vivo carcinoma cells induced by IFN-gamma or by a binding peptide.

Cellular immunology·1992

The origin and significance of anti-DNA antibodies.

Immunology today·2014

Mutations of class II MHC molecules.

Immunology today·2014

Antigen processing at the molecular level.

Immunology today·2014

Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.

Immunology today·2014

Are MHC class II-restricted cytotoxic T lymphocytes important?

Immunology today·2014

Complement and the regulation of humoral immune responses.

Immunology today·2014

Serological correlates of disseminated Borrelia burgdorferi infection in mouse models of tick challenge.

Microbiology spectrum·2026

IgG4-related disease - treatment with anti-CD20, anti-CD19 antibodies, and other new drugs.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026

[Advances in mechanical signal-regulated tumor immunity and its therapeutic development].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences·2026

Cytokine-independent activation of STAT5 promotes the persistence and function of CD4+ regulatory T cells.

Molecular therapy. Advances·2026

CAR design equips diverse immune cells with unique antigen-specific activation identities.

Molecular therapy. Oncology·2026

Therapeutic potential of ginseng and its bioactive compounds in inflammatory bowel disease: current evidence and future directions.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us